MSD Animal Health, which offers innovative veterinary pharmaceuticals and vaccines, services and technologies to prevent, treat and control animal diseases, completed the acquisition of Vilsan Pharmaceuticals, a producer of animal health products, from Vimar, a provider of animal health products and services. Financial terms were not disclosed. “We are very pleased to join with MSD Animal Health to build upon our 30-year commitment to advance the health of animals. Their expertise, commercial reach and worldwide network, combined with our portfolio and production capacity, represents a tremendous opportunity to serve producers and veterinarians in this region,” Burhan Haci, Vilsan Pharmaceuticals CEO.